LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 16,351 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 16,351 | -5.8% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 17,351 | -16.0% | 0.00% | -100.0% |
| Q4 2022 | $843 | -99.9% | 20,659 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $843,000 | -30.2% | 20,659 | -6.0% | 0.00% | -33.3% |
| Q2 2022 | $1,208,000 | +1.2% | 21,968 | -33.2% | 0.01% | +50.0% |
| Q1 2022 | $1,194,000 | -0.8% | 32,865 | +27.2% | 0.00% | 0.0% |
| Q4 2021 | $1,204,000 | +18.3% | 25,830 | +28.3% | 0.00% | 0.0% |
| Q3 2021 | $1,018,000 | -54.5% | 20,128 | -63.1% | 0.00% | 0.0% |
| Q2 2021 | $2,238,000 | +41.5% | 54,508 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $1,582,000 | -76.6% | 54,508 | +24.6% | 0.00% | 0.0% |
| Q4 2020 | $6,774,000 | +63.3% | 43,738 | -67.4% | 0.00% | -75.0% |
| Q3 2020 | $4,148,000 | – | 134,332 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |